1. Home
  2. CSGS vs STOK Comparison

CSGS vs STOK Comparison

Compare CSGS & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSG Systems International Inc.

CSGS

CSG Systems International Inc.

HOLD

Current Price

$79.85

Market Cap

2.2B

Sector

Technology

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$30.11

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSGS
STOK
Founded
1994
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
CSGS
STOK
Price
$79.85
$30.11
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$72.96
$34.50
AVG Volume (30 Days)
481.9K
707.9K
Earning Date
02-03-2026
11-04-2025
Dividend Yield
1.60%
N/A
EPS Growth
29.70
N/A
EPS
2.95
0.68
Revenue
$1,216,848,000.00
$205,632,000.00
Revenue This Year
$2.90
$430.24
Revenue Next Year
$4.71
N/A
P/E Ratio
$27.05
$43.08
Revenue Growth
3.31
1128.17
52 Week Low
$52.94
$5.35
52 Week High
$79.88
$38.69

Technical Indicators

Market Signals
Indicator
CSGS
STOK
Relative Strength Index (RSI) 76.87 45.95
Support Level $79.40 $27.01
Resistance Level $79.69 $31.70
Average True Range (ATR) 0.30 2.17
MACD 0.08 -0.42
Stochastic Oscillator 87.67 39.65

Price Performance

Historical Comparison
CSGS
STOK

About CSGS CSG Systems International Inc.

CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: